NEW YORK (GenomeWeb) – MDxHealth said today that American Pathology Partners will promote and co-market the firm's ConfirmMDx for Prostate Cancer test in the US.

American Pathology Partners is building a network of pathology labs in the US and has partnered in that effort with UniPath in Denver, Palm Beach Pathology in West Palm Beach, Fla., and Eastern Carolina Pathology in Wilson, NC. MDxHealth said the agreement extends its customer base to pathologists serving urologists in key geographic markets.

Financial and other terms of the agreement weren't disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.